Us Bancorp \De\ Aclaris Therapeutics, Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$7.89 - $10.64 $1,791 - $2,415	227 Added 43.07%	754 $7,000
Q1 2023 May 09, 2023	BUY	$7.07 - $17.95 $3,252 - $8,257	460 Added 686.57%	527 $4,000
Q3 2022 Oct 27, 2022	BUY	$13.07 - $18.22 $875 - $1,220	67 New	67 $1,000
Q3 2018 Nov 01, 2018	SELL	$14.38 - $20.89 $977 - $1,420	-68 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$16.46 - $20.33 $1,119 - $1,382	68 New	68 $1,000

80.7M

257K

92.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $155M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.